| Baclofen | Lioresal® (injection) (Medtronic, Inc.) | Management of severe spasticity of spinal cord origin in patients who are unresponsive to oral baclofen therapy or experience intolerable CNS side effects at effective doses. | Drug Information Portal
MedlinePlus |
| Dalfampridine | Ampyra (Acorda Therapeutics) | Treatment to improve walking in patients with multiple sclerosis (MS) | Drug Information Portal
|
| Glatiramer acetate | Copaxone® (Teva Pharmaceuticals USA) | For reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis. | Drug Information Portal
MedlinePlus |
| Interferon beta-1a (recombinant human) | Avonex® (Biogen, Inc.) | Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations. | Drug Information Portal
MedlinePlus |
| Interferon beta-1b | Betaseron® (Bayer) | In ambulatory patients with relapsing-remitting multiple sclerosis to reduce the frequency of clinical exacerbations. | Drug Information Portal
MedlinePlus |